Stryker (NYSE:SYK) Director Ronda Stryker Sells 300,000 Shares of Stock

Stryker Corporation (NYSE:SYK) Director Ronda Stryker sold 300,000 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total value of $100,770,000.00. Following the completion of the sale, the director directly owned 2,301,375 shares of the company’s stock, valued at approximately $773,031,862.50. This trade represents a 11.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Stryker Stock Down 3.5%

Stryker stock opened at $327.97 on Friday. The firm has a market capitalization of $125.80 billion, a price-to-earnings ratio of 33.99, a PEG ratio of 2.17 and a beta of 0.76. The company’s 50 day simple moving average is $326.64 and its 200 day simple moving average is $332.66. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $396.86.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating the consensus estimate of $3.49 by $0.20. The firm had revenue of $6.59 billion during the quarter, compared to the consensus estimate of $6.58 billion. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, sell-side analysts anticipate that Stryker Corporation will post 15.02 EPS for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a $0.88 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. Stryker’s dividend payout ratio is currently 36.48%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on SYK. Royal Bank Of Canada decreased their target price on Stryker from $435.00 to $420.00 and set an “outperform” rating for the company in a research note on Friday, July 31st. The Goldman Sachs Group reiterated a “neutral” rating and issued a $361.00 price objective on shares of Stryker in a research report on Friday, May 1st. Sanford C. Bernstein set a $410.00 target price on Stryker in a research note on Friday, May 1st. Piper Sandler dropped their target price on shares of Stryker from $420.00 to $390.00 and set an “overweight” rating on the stock in a report on Friday, July 31st. Finally, Robert W. Baird set a $385.00 price target on shares of Stryker in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Stryker presently has an average rating of “Moderate Buy” and an average price target of $386.28.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Banco de Sabadell S.A grew its holdings in shares of Stryker by 1.3% during the second quarter. Banco de Sabadell S.A now owns 5,843 shares of the medical technology company’s stock worth $1,848,000 after buying an additional 74 shares in the last quarter. Chesapeake Wealth Management lifted its stake in Stryker by 15.1% in the 2nd quarter. Chesapeake Wealth Management now owns 1,665 shares of the medical technology company’s stock valued at $524,000 after acquiring an additional 218 shares in the last quarter. Proficio Capital Partners LLC acquired a new position in Stryker during the 2nd quarter worth approximately $657,000. Community Bank & Trust Waco Texas boosted its position in Stryker by 2.3% during the 2nd quarter. Community Bank & Trust Waco Texas now owns 1,395 shares of the medical technology company’s stock worth $439,000 after acquiring an additional 31 shares during the last quarter. Finally, Nwam LLC grew its stake in shares of Stryker by 51.6% during the 2nd quarter. Nwam LLC now owns 11,963 shares of the medical technology company’s stock worth $3,767,000 after acquiring an additional 4,071 shares in the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.